Schond Greenway

Insider Reports History

Entity
Individual
Location
C/O Cerecor, Inc., 540 Gaither Road, Suite 400, Rockville, MD
Signature
/s/ Mark Sullivan, Attorney-in-Fact for Schond Greenway
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Schond Greenway:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mind Medicine (MindMed) Inc. Chief Financial Officer Common Shares 211K $2.06M $9.78 Mar 25, 2024 Direct
Avalo Therapeutics, Inc. CFO Common Stock 3.88K $2.02K $0.52 Dec 10, 2021 Direct
Mind Medicine (MindMed) Inc. Chief Financial Officer Stock Option (Right to Buy) 150K Feb 27, 2024 Direct

Insider Reports Filed by Schond Greenway

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNMD Mind Medicine (MindMed) Inc. Mar 25, 2024 1 -$54.4K 4 Mar 26, 2024 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. Feb 27, 2024 1 $0 4 Feb 29, 2024 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. Dec 26, 2023 1 -$20.5K 4 Dec 26, 2023 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. Sep 25, 2023 2 -$20.6K 4 Sep 25, 2023 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. Aug 25, 2023 1 -$76K 4 Aug 28, 2023 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. Jun 27, 2023 2 -$37.2K 4 Jun 27, 2023 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. Mar 14, 2023 1 $0 4/A Apr 24, 2023 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. May 23, 2022 2 $0 4/A Jun 3, 2022 Chief Financial Officer
MNMD Mind Medicine (MindMed) Inc. May 23, 2022 0 $0 3 May 23, 2022 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Dec 10, 2021 1 $3.5K 4 Dec 14, 2021 CFO
AVTX Cerecor Inc. Jun 10, 2021 1 $1.75K 4 Jun 14, 2021 CFO